{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/melanoma-pigmented-lesions/","result":{"data":{"firstChapter":{"id":"6f710641-b9e2-5edc-aeed-890a7095cd96","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 37c1d901-e1d0-4b5f-b279-aef2a943f015 --><h1>Melanoma and pigmented lesions: Summary</h1><!-- end field 37c1d901-e1d0-4b5f-b279-aef2a943f015 -->","htmlStringContent":"<!-- begin item c9d0c8dd-bbb5-4067-b855-9bd5cab2a14c --><!-- begin field d3c06a26-4568-4b54-a5c1-6c9d5d1c8ab3 --><ul><li>A melanoma of the skin is a malignant tumour arising from melanocytes in the skin. There are four common subtypes — superficial spreading melanoma, nodular melanoma, lentigo maligna melanoma, and acral lentiginous melanoma.</li><li>Other types of pigmented lesions include:<ul><li>Moles (naevi) — including blue naevi, halo naevi, and Meyerson's naevi.</li><li>Seborrhoeic keratoses.</li><li>Dermatofibromas.</li><li>Freckles.</li><li>Lentigines.</li><li>Pigmented basal cell carcinomas.</li></ul></li><li>The incidence of melanoma is increasing. There were 15,400 new cases of melanoma skin cancer in the UK in 2014, making it the fifth most common cancer. </li><li>Factors that increase the risk of melanoma include:<ul><li>A personal history of skin cancer. </li><li>A family history of skin cancer. </li><li>Pale skin (type I and II) that does not tan easily and burns; light-coloured eyes.</li><li>Red, blond or light-coloured hair.</li><li>Blue or green eyes.</li><li>History of sunburn, particularly blistering sunburn in childhood.</li><li>A history of indoor tanning.</li><li>A large number of moles.</li><li>Increasing age.</li><li>Organ transplant recipients.</li></ul></li><li>Prognosis is dependent on the stage of the melanoma, which depends on the thickness, level of ulceration and spread to local lymph nodes. </li><li>Pigmented lesions which 'stand out from the crowd' because they are different (the 'Ugly Duckling sign') are a cause for concern, especially if they are changing. The Weighted 7-point checklist may be used to assess pigmented skin lesions, and determine referral: <ul><li>Major features of the lesion (2 points each): change in size, irregular shape or border, irregular colour.</li><li>Minor features of the lesion (1 point each): largest diameter 7 mm or more, inflammation, oozing or crusting of the lesion, change in sensation (including itch).</li><li>Suspicion is greater for lesions scoring 3 points or more. However, if there are strong concerns about cancer, any one feature is adequate to prompt urgent referral under the 2-week rule.</li></ul></li><li>Urgent referral (within 2 weeks) to a specialist with experience of melanoma diagnosis is required for:<ul><li>Lesions suggestive of malignant melanoma (including nodular and amelanotic melanoma).</li><li>Lesions which score 3 points or more (based on major features scoring 2 points each and minor features scoring 1 point each) on the 7-point checklist. However, any one feature can be adequate to prompt urgent referral.</li><li>New nodules, which are pigmented, or vascular in appearance.</li><li>Nail changes, such as a new pigmented line in the nail or something growing under the nail.</li><li>Any doubt about the diagnosis of the lesion.</li><li>Skin conditions which are persistent or slowly evolving and unresponsive to treatment, with an uncertain diagnosis and melanoma is a possibility.</li><li>Biopsy confirmed diagnosis of malignant melanoma. Excision of suspected melanoma in primary care should be avoided.</li></ul></li></ul><!-- end field d3c06a26-4568-4b54-a5c1-6c9d5d1c8ab3 --><!-- end item c9d0c8dd-bbb5-4067-b855-9bd5cab2a14c -->","topic":{"id":"f5efb7d1-47fd-5e6a-a34d-95395f7523a0","topicId":"c296c560-d236-46ad-abcc-52c1fc0a1abf","topicName":"Melanoma and pigmented lesions","slug":"melanoma-pigmented-lesions","aliases":["Pigmented lesions and melanoma"],"chapters":[{"id":"6f710641-b9e2-5edc-aeed-890a7095cd96","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"88e3acd7-3799-5638-93fc-4739079b0f26","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"4cd2dca8-d311-5805-aea1-3870f6f4fccd","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"4b752af4-f177-5a66-a15f-20135ef4c005","slug":"changes","fullItemName":"Changes"},{"id":"a75a8fa4-d7d6-5932-b9a5-1d5af0bc564e","slug":"update","fullItemName":"Update"}]},{"id":"37450e93-1f0f-5e02-8d33-091798b27dd1","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"37acfb65-9e83-5bb2-b261-3d35d43dc478","slug":"goals","fullItemName":"Goals"},{"id":"c2f69e41-ef64-5440-97db-a9d74ccdb90f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d7224a15-69f9-5519-a181-db44131ecc01","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5489c4c1-2dd5-5679-9dc8-3b4c8136dcb7","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c5779c9e-ebcd-5682-9817-797e8b88a2f6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"0f3ef819-faeb-58c1-b3a8-029ddf2d2ec2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"97595147-c6d8-569e-8edd-b38e54974224","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"b87206e4-fbe6-5ff3-b4db-757e2bdce473","slug":"definition","fullItemName":"Definition"},{"id":"7f5895c0-5070-5a7b-b402-836e18bde1fb","slug":"features","fullItemName":"Features"},{"id":"28380e7d-9dea-5a1f-9be7-1d7ac0e5a123","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"7f9731f8-f8a0-5020-95ad-4220ee1b085a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"fa22327f-becb-5e32-803b-7ff99e765cd1","slug":"prognosis","fullItemName":"Prognosis"},{"id":"ed48057f-9e82-56c6-8846-040b30894b15","slug":"non-melanotic-lesions","fullItemName":"Non-melanotic lesions"},{"id":"aaaf9edb-2903-5b78-831c-b7839586fdfe","slug":"other-pigmented-lesions","fullItemName":"Other pigmented lesions"}]},{"id":"5b41a523-ea89-5f11-bbd5-21118fe0f7b2","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"2a182f91-5ece-564a-a4e3-83ea99005110","slug":"assessment","fullItemName":"Assessment"},{"id":"bb757fc9-32cf-5a88-b59d-3b676b8fe2f0","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"260b59e0-5f81-5189-b2b1-781e2a96257a","slug":"biopsy-of-the-lesion","fullItemName":"Biopsy of the lesion"}]},{"id":"2a84a2c2-8b7a-582d-9ab2-4a4d23728f10","slug":"management","fullItemName":"Management","subChapters":[{"id":"01c409db-6041-5f5d-8faf-ad2b86d6a736","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"b70563d4-10f0-517e-ab86-50e2e260e966","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[{"id":"84e1f7c4-66db-59e5-b9a9-1fc097979aa4","slug":"evidence-on-the-abcd-7-point-checklists","fullItemName":"Evidence on the ABCD and 7-point checklists"},{"id":"68448720-3dbd-530e-bf51-0c8d618ee81e","slug":"evidence-on-self-examination-for-early-melanoma-detection","fullItemName":"Evidence on self-examination for early melanoma detection"}]},{"id":"560a3b23-0b91-5538-a7e7-2b8d61f1dfed","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"9e328671-9080-5494-aeca-8cca3a845389","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7968cb4d-c0a4-51ae-bc15-16ce3025ca18","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f3daadc2-eacf-5bcf-8acb-473fa56481df","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"47ede055-d8df-5c65-8d5e-4189da7ac034","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d2c30ae3-8839-58ef-8a53-f015bff32373","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"02f003b7-53e6-52fe-8c98-bc5580019357","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"f5efb7d1-47fd-5e6a-a34d-95395f7523a0","topicId":"c296c560-d236-46ad-abcc-52c1fc0a1abf","topicName":"Melanoma and pigmented lesions","slug":"melanoma-pigmented-lesions","aliases":["Pigmented lesions and melanoma"],"topicSummary":"A melanoma of the skin is a malignant tumour arising from melanocytes in the skin.","lastRevised":"Last revised in March 2017","nextPlannedReviewBy":"2022-03-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2022-03","nextPlannedReviewByDisplay":"March 2022","specialities":[{"id":"2454765b-1b2d-53fc-b288-17b66486f41a","name":"Preventative medicine","slug":"preventative-medicine"},{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"}],"chapters":[{"id":"6f710641-b9e2-5edc-aeed-890a7095cd96","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"88e3acd7-3799-5638-93fc-4739079b0f26","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"4cd2dca8-d311-5805-aea1-3870f6f4fccd","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"4b752af4-f177-5a66-a15f-20135ef4c005","slug":"changes","fullItemName":"Changes"},{"id":"a75a8fa4-d7d6-5932-b9a5-1d5af0bc564e","slug":"update","fullItemName":"Update"}]},{"id":"37450e93-1f0f-5e02-8d33-091798b27dd1","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"37acfb65-9e83-5bb2-b261-3d35d43dc478","slug":"goals","fullItemName":"Goals"},{"id":"c2f69e41-ef64-5440-97db-a9d74ccdb90f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d7224a15-69f9-5519-a181-db44131ecc01","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"5489c4c1-2dd5-5679-9dc8-3b4c8136dcb7","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c5779c9e-ebcd-5682-9817-797e8b88a2f6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"0f3ef819-faeb-58c1-b3a8-029ddf2d2ec2","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"97595147-c6d8-569e-8edd-b38e54974224","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"b87206e4-fbe6-5ff3-b4db-757e2bdce473","slug":"definition","fullItemName":"Definition"},{"id":"7f5895c0-5070-5a7b-b402-836e18bde1fb","slug":"features","fullItemName":"Features"},{"id":"28380e7d-9dea-5a1f-9be7-1d7ac0e5a123","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"7f9731f8-f8a0-5020-95ad-4220ee1b085a","slug":"prevalence","fullItemName":"Prevalence"},{"id":"fa22327f-becb-5e32-803b-7ff99e765cd1","slug":"prognosis","fullItemName":"Prognosis"},{"id":"ed48057f-9e82-56c6-8846-040b30894b15","slug":"non-melanotic-lesions","fullItemName":"Non-melanotic lesions"},{"id":"aaaf9edb-2903-5b78-831c-b7839586fdfe","slug":"other-pigmented-lesions","fullItemName":"Other pigmented lesions"}]},{"id":"5b41a523-ea89-5f11-bbd5-21118fe0f7b2","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"2a182f91-5ece-564a-a4e3-83ea99005110","slug":"assessment","fullItemName":"Assessment"},{"id":"bb757fc9-32cf-5a88-b59d-3b676b8fe2f0","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"260b59e0-5f81-5189-b2b1-781e2a96257a","slug":"biopsy-of-the-lesion","fullItemName":"Biopsy of the lesion"}]},{"id":"2a84a2c2-8b7a-582d-9ab2-4a4d23728f10","slug":"management","fullItemName":"Management","subChapters":[{"id":"01c409db-6041-5f5d-8faf-ad2b86d6a736","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"b70563d4-10f0-517e-ab86-50e2e260e966","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[{"id":"84e1f7c4-66db-59e5-b9a9-1fc097979aa4","slug":"evidence-on-the-abcd-7-point-checklists","fullItemName":"Evidence on the ABCD and 7-point checklists"},{"id":"68448720-3dbd-530e-bf51-0c8d618ee81e","slug":"evidence-on-self-examination-for-early-melanoma-detection","fullItemName":"Evidence on self-examination for early melanoma detection"}]},{"id":"560a3b23-0b91-5538-a7e7-2b8d61f1dfed","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"9e328671-9080-5494-aeca-8cca3a845389","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7968cb4d-c0a4-51ae-bc15-16ce3025ca18","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f3daadc2-eacf-5bcf-8acb-473fa56481df","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"47ede055-d8df-5c65-8d5e-4189da7ac034","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d2c30ae3-8839-58ef-8a53-f015bff32373","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"02f003b7-53e6-52fe-8c98-bc5580019357","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"f5efb7d1-47fd-5e6a-a34d-95395f7523a0"}},"staticQueryHashes":["3666801979"]}